NORWOOD, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology and obesity company with a diversified portfolio, announced today that it has completed enrollment of the dose escalation part of its bridging Phase 1 clinical trial of CRB-701 (SYS6002). The dose escalation part of this open label study (NCT06265727) is being conducted in the US and the UK. The three-part Phase 1 trial is evaluating the safety, pharmacokinetics and ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Roberts Berzins has over a decade of experience in the financial management helping top-tier corporates shape their financial strategies and execute large-scale financings. He has also made significant efforts to institutionalize REIT framework in Latvia to boost the liquidity of pan-Baltic capital markets. Other policy-level work includes the development of national SOE financing guidelines and framework for channeling private capital into affordable housing stock. Roberts is a CFA Charterholder, ESG inves ...

Join iREIT® on Alpha today to get the most in-depth research that includes REITs, mREIT, Preferreds, BDCs, MLPs, ETFs, Builders, and Asset Managers. Our iREIT® Tracker provides data on over 250 tickers with our quality scores, buy targets, and trim targets.As many of my long-time readers know, I have been writing on the Seeking Alpha platform for almost 15 years.Brad, along with HOYA Capital, lead the investing group iREIT®+HOYA Capital. The service covers REITs, BDCs, MLPs, Preferreds, and other income-ori ...

Increase Results in 2.4% Year-Over-Year Growth and Annualized Dividend of $3.036 Per ShareROYAL OAK, Mich., Oct. 10, 2024  /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a monthly cash dividend of $0.253 per common share, representing a 1.2% month-over-month increase. The monthly dividend reflects an annualized dividend amount of $3.036 per common share, representing a 2.4% increase over the annua ...

Proprietary cell-free platform enables the design of next-generation ADCs intended to broaden addressable patient populations STRO-004 (tissue factor ADC) preclinical data has demonstrated greater anti-tumor activity and lower toxicity compared to a benchmark tissue factor ADC Preclinical models highlight potent anti-tumor activity of Sutro dual-payload (ADC2) and immunostimulatory (iADC) ADCs Expects to deliver three Investigational New Drug (IND) applications over the next three years with potential for b ...

Group 1 - The article discusses two blue-chip companies that are considered suitable for retirement portfolios, specifically mentioning Enterprise Products Partners [1] - The author emphasizes the importance of these companies in shaping financial strategies and executing large-scale financings [1] - The article highlights the efforts made to institutionalize REIT frameworks in Latvia to enhance liquidity in pan-Baltic capital markets [1] Group 2 - The author has a beneficial long position in the shares of specific companies, indicating a personal investment interest [2] - The article expresses the author's opinions without any compensation from the companies mentioned, ensuring an independent viewpoint [2] - There is a disclaimer regarding past performance not guaranteeing future results, emphasizing the need for individual assessment of investment suitability [2]

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREIT, Preferreds, BDCs, MLPs, ETFs, and we recently added Prop Tech SPACs to the lineup. We are also adding an all-new Ratings Tracker this week called iREIT Buy Zone to help members screen for value. Nothing to lose with our FREE 2-week trial .Brad, along with HOYA Capital, lead the investing group iREIT®+HOYA Capital. The service covers REITs, BDCs, MLPs, Preferreds, and other income-oriented alternatives. The team of analys ...

Group 1 - The article highlights the importance of significant effort in achieving initial wealth, specifically referencing the first $100,000 as a critical milestone [1] - Roberts Berzins has over a decade of experience in financial management, focusing on shaping financial strategies for top-tier corporates and executing large-scale financings [1] - Berzins has contributed to institutionalizing the REIT framework in Latvia to enhance the liquidity of pan-Baltic capital markets [1] Group 2 - The article mentions Berzins' involvement in developing national SOE financing guidelines and frameworks to channel private capital into affordable housing [1] - Berzins holds a CFA Charter and an ESG investing certificate, indicating a strong background in finance and sustainable investing [1] - His experience includes an internship at the Chicago Board of Trade, showcasing a diverse professional background despite residing in Latvia [1]

Group 1 - The article emphasizes the importance of quality dividends over the quantity of distributions, suggesting a preference for monthly distributions compared to quarterly ones [1] - iREIT®+HOYA Capital, led by Brad Thomas, focuses on various income-oriented investments including REITs, BDCs, MLPs, and Preferreds, with a team of analysts boasting over 100 years of combined experience [1] - Brad Thomas has extensive experience in real estate investing, having been involved in over $1 billion in commercial real estate transactions and is a published author on the subject [2] Group 2 - The article mentions the addition of a new Ratings Tracker called iREIT Buy Zone, aimed at helping members identify value in the market [1] - The team includes professionals with diverse backgrounds, including a former hedge fund manager and an advisor to a former U.S. President, enhancing the credibility of the research [1]